510(k) device
Sentinel Lithium Assay
SENTINEL CH. SpA · Assay, Porphyrin, Spectrophotometry, Lithium (NDW, Class II) · First FDA decision Aug 2, 2007, newest Aug 2, 2007Depression
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
113
Naming "Sentinel"
MAUDE reports
430
Brand "Sentinel", since 2015
PubMed studies
41,127
Mentioning "Sentinel"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- SENTINEL LITHIUM ASSAY510(k)
K070987 · Decided Aug 2, 2007 · 118 days after receipt
Device type: Assay, Porphyrin, Spectrophotometry, Lithium (NDW) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Sentinel", any status and sponsor, newest update first.
Ss. Cyril and Methodius University of SkopjeAcademic, hospital or other
NCT07696754 · 200 participants (planned) · Start Nov 2026 · Primary completion Oct 2029
Device: Augmented-reality ICG fluorescence second-look imaging · For: Breast Cancer; Breast Neoplasms; Sentinel Lymph Node and 1 more
Sites: Skopje, North Macedonia
Ss. Cyril and Methodius University of SkopjeAcademic, hospital or other
NCT07683572 · 0 participants · Start Jul 1, 2026 · Primary completion Jul 1, 2028
Device: AR-ICG near-infrared fluorescence imaging · For: Breast Cancer; Breast Neoplasms; Sentinel Lymph Node and 1 more
Sites: Skopje, North Macedonia
- Sola2 AMF Knee System Added to Surgery and Antibiotics in Adults With Knee Implant InfectionPivotal-lookingRecruiting
Solenic Medical, Inc.Not on our public-company list
NCT07700927 · 165 participants (planned) · Start Oct 30, 2026 · Primary completion Aug 2028
Device: Intervention 1: Alternating Magnetic Field Treatment; Intervention 2 - Sham Treatment · For: Prosthetic Joint Infection of Knee
Sites: New Albany, Ohio; Tulsa, Oklahoma
- Plasmonic PhotoThermal Therapy (PPTT) With Glucose-Coated Gold Nanoparticles (TSK-001) in Patients With Nodular Basal Cell Carcinoma (nBCC)Not yet recruiting
Torskal SASAcademic, hospital or other
NCT07891949 · 78 participants (planned) · Start Oct 2026 · Primary completion Oct 2026
Device: TSK-001. Injectable solution of glucose-functionalised plasmonic gold nanoparticles (0.3 mg in 1 mL water for injection) for intratumoural administration.; 808 nm near-infrared (NIR) diode laser (Hyper Diode 808) · For: Nodular BCC
Sites: Wellington, New Zealand
Metehan UzundalGovernment (non-federal)
NCT07882277 · 70 participants (planned) · Start Oct 2026 · Primary completion Jan 2028
Device: 27-Inch Endoscopic Imaging Monitor; 55-Inch Endoscopic Imaging Monitor · For: Endometrial Cancer
Sites: Istanbul, Turkey (Türkiye)
- Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use DisorderNot yet recruiting
Clive MichelsenNot on our public-company list
NCT07871877 · 60 participants (planned) · Start Jul 1, 2027 · Primary completion Jan 31, 2029
Device: My-E-Health SENTINEL Digital Monitoring and Human-Gated Escalation Platform · For: Opioid Use Disorder; Opioid Withdrawal; Substance Use Disorders
Sites: Basalt, Colorado
Beijing Friendship HospitalAcademic, hospital or other
NCT07835087 · 36 participants (planned) · Start Aug 14, 2026 · Primary completion Aug 14, 2027
Device: Image-Guided Retrieval Specimen Platform · For: Early Gastric Cancer; Gastric Adenocarcinoma
Sites: Beijing, China
- Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma: MagMen-IIPivotal-lookingNot yet recruiting
Vastra Gotaland RegionGovernment (non-federal)
NCT07552597 · 254 participants (planned) · Start Oct 1, 2026 · Primary completion Dec 31, 2030
Device: Superparamagnetic Iron Oxide · For: Melanoma (Skin Cancer)
Institut de Cancérologie de LorraineAcademic, hospital or other
NCT02997553 · 744 participants · Start Nov 29, 2017 · Primary completion Sep 19, 2022
Device: Optonuclear probe; Quest Camera · For: Breast Carcinoma; Head and Neck Cancer; Melanoma (Skin) and 7 more
Sites: Vandœuvre-lès-Nancy, France
- CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic MaterialPivotal-lookingRecruiting
EmStop IncNot on our public-company list
NCT07276711 · 663 participants (planned) · Start May 12, 2026 · Primary completion May 2028
Device: EmStop Embolic Protection System; Boston Scientific Sentinel · For: Aortic Valve Stenosis; Aortic Stenosis; Aortic Valve Disease
Sites: Thousand Oaks, California; Clearwater, Florida; New Orleans, Louisiana · 7 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Sentinel", and for the whole product code for context.
This brand
430 reports: 336 malfunction, 88 injury, 6 death
Whole product code NDW
7 reports: 7 malfunction, 0 injury, 0 death
Newest reports for this brand
- SentinelMalfunction
2124215-2026-53733 · Received Oct 9, 2026 · Event dated Oct 6, 2026
Device type: Temporary Catheter, Embolic Protection, Transcatheter Intracardiac Procedures (PUM)
Device problem as coded: Nonstandard Device; Difficult to Remove
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SentinelMalfunction
2124215-2026-53309 · Received Oct 7, 2026 · Event dated Oct 1, 2026
Device type: Temporary Catheter, Embolic Protection, Transcatheter Intracardiac Procedures (PUM)
Device problem as coded: Contamination
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SentinelMalfunction
50945602 · Received Sep 30, 2026 · Event dated Jun 9, 2026
Device type: Temporary Catheter, Embolic Protection, Transcatheter Intracardiac Procedures (PUM)
Device problem as coded: Device Damaged by Another Device; Activation Failure
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SentinelMalfunction
2124215-2026-49257 · Received Sep 15, 2026 · Event dated Jul 21, 2026
Device type: Temporary Catheter, Embolic Protection, Transcatheter Intracardiac Procedures (PUM)
Device problem as coded: Nonstandard Device; Failure to Unfold or Unwrap; Difficult to Advance
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SentinelInjury
2124215-2026-48756 · Received Sep 11, 2026 · Event dated Jul 15, 2026
Device type: Temporary Catheter, Embolic Protection, Transcatheter Intracardiac Procedures (PUM)
Device problem as coded: Mechanical Jam
Patient problem as coded: Stroke/CVA
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2551-2019 · Started Jun 28, 2019
Reason given: Added an additional SmartWash parameter for the Lithium and Alinity c Lithium Reagent Kit, catalogue number 8L25-30 and 08P5320 to prevent the potential for carryover from the ARCHITECT Lactate Dehydrogenase (LDH) reagent (LN 2P56) may result infalsely elevated lithium patient results
Cause as FDA categorized it: Under Investigation by firm · Device type: Assay, Porphyrin, Spectrophotometry, Lithium (NDW)
Z-2552-2019 · Started Jun 28, 2019
Reason given: Added an additional SmartWash parameter for the Lithium and Alinity c Lithium Reagent Kit, catalogue number 8L25-30 and 08P5320 to prevent the potential for carryover from the ARCHITECT Lactate Dehydrogenase (LDH) reagent (LN 2P56) may result infalsely elevated lithium patient results
Cause as FDA categorized it: Under Investigation by firm · Device type: Assay, Porphyrin, Spectrophotometry, Lithium (NDW)
Published research
The most relevant PubMed records for "Sentinel"[tiab]. The summary above synthesizes these.
- Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.
Kuehn T, Bauerfeind I, Fehm T, et al. · Lancet Oncol · 2013Comparative Study, Multicenter Study
- Sentinel Node Biopsy for Nonmelanoma Skin Cancer of the Head and Neck.
Sethi R, Emerick K · Otolaryngol Clin North Am · 2021Review
- Sentinel lymph node biopsy for lung cancer.
Gregor A, Ujiie H, Yasufuku K · Gen Thorac Cardiovasc Surg · 2020Review
- Sentinel lymph node biopsy in extramammary Paget disease: A 13-year institutional experience.
Maeda T, Nagai K, Uehara J, et al. · J Dermatol · 2023
- Sentinel injuries: subtle findings of physical abuse.
Petska HW, Sheets LK · Pediatr Clin North Am · 2014Review
- Status of Sentinel Lymph Node Biopsy in Endometrial Cancer.
Taran FA, Jung L, Waldschmidt J, et al. · Geburtshilfe Frauenheilkd · 2021
- Sentinel node biopsy and improved patient care.
Giuliano AE, Gangi A · Breast J · 2015Historical Article, Research Support, Non-U.S. Gov't
- Atypical Spitz tumours and sentinel lymph node biopsy: a systematic review.
Lallas A, Kyrgidis A, Ferrara G, et al. · Lancet Oncol · 2014Research Support, Non-U.S. Gov't, Systematic Review
- Single-port endoscopic-sentinel lymph node biopsy combined with indocyanine green and carbon nanoparticles in breast cancer.
Wang ZH, Gang TR, Wu SS, et al. · Surg Endosc · 2023Observational Study, Research Support, Non-U.S. Gov't
- What's in a name? Sentinel injuries in abused infants.
Henry MK, Wood JN · Pediatr Radiol · 2021Review
- Aberrant sentinel nodes in malignant melanoma.
O'Toole GA, Hettiaratchy S, Allan R, et al. · Br J Plast Surg · 2000
- vNOTES sentinel nodes removal from a remaining cervix.
Badiglian-Filho L, Burnett A, Matak L, et al. · J Gynecol Obstet Hum Reprod · 2026Video-Audio Media
Other devices of this type
Also filed under product code NDW.
- Diazyme Colorimetric Lithium AssayDiazyme Laboratories, Inc. · 510(k) 2025
- Dimension Vista Lithium Flex Reagent CartridgeSiemens Healthcare Diagnostics · 510(k) 2011
- Cobas LithiumRoche Diagnostics Corp. · 510(k) 2008
- Lithium Micro Volume ElectrodeThermo Electron OY · 510(k) 2007
- Advia Ims Lithium AssayBayer Healthcare, LLC · 510(k) 2005
- Lithium Regent Model TR66056 / Lithium Standard TR66901Trace America, Inc. · 510(k) 2001
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.